Allon Gillispie in Duncan, Oklahoma

Home Oklahoma Duncan

Allon Gillispie has Family Practice as his primary medical specialty. Their primary office is: 2434 Harville Rd in Duncan, Oklahoma. There are 6 additional office locations for Allon Gillispie that can be viewed towards the end of their profile.

They're a part of the: Duncan Regional Hospital, Inc. medical group which has around 42 members. You can call their office at 580-252-1373 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Oklahoma State University College Of Osteopathic Medicine and graduated in 2020 (around 4 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Allon Gillispie Office Phone and Directions

Allon Gillispie
Duncan Regional Hospital, Inc.
2434 Harville Rd
Duncan, Oklahoma 73533
580-252-1373

Patient Ratings
Please rate your experience with Allon Gillispie below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 580-252-1373

Enter a starting address:

Healthcare Info for Allon Gillispie

Medical School: Oklahoma State University College Of Osteopathic Medicine
Graduation Year: 2020
The Primary Medical Specialty for Allon Gillispie is listed as: Family Practice
Approximate Years of Experience: 4
PAC (PECOS ID)#: 0244624435
NPI #: 1508246570
NPI Created On: 06/04/2015
NPI Last Updated Listed as: 07/05/2023
Primary Taxonomy Code: 207Q00000X
License Number:
0356R
Listed Gender: Male

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 837244999

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CONTRACEPTIVES

Name of Drug #1: NEXPLANON

Open Associated Drug #1: 78206-145-01

Payments Total: $1